Previous 10 | Next 10 |
2023-04-06 15:42:00 ET Shares of Heron Therapeutics (NASDAQ: HRTX) stormed higher by 47% over the first 3 1/2 days of trading this week, according to data provided by S&P Global Market Intelligence . The big gain came in response to the appointment of Craig Collard as Ch...
2023-04-06 14:01:00 ET Shares of Heron Therapeutics (NASDAQ: HRTX) were up more than 19% early Thursday afternoon. The biopharmaceutical company, which has been focusing on post-surgery therapeutics, has been on a steady rise since the company announced on Monday that it was appoint...
2023-04-06 13:25:31 ET Gainers: Guardforce AI ( GFAI ) +61% . Amesite ( AMST ) +31% . Tellurian ( TELL ) +29% . The Singing Machine Company ( MICS ) +27% . Cardlytics ( CDLX ) +22% . Finance Of America Companies ( FOA ) ...
2023-04-03 10:02:08 ET Gainers: Heska ( HSKA ) +20% . Heron Therapeutics ( HRTX ) +19% . InterCure ( INCR ) +17% . Innate Pharma ( IPHA ) +15% . Apellis Pharmaceuticals ( APLS ) +14% . Losers: OncoSec Medical ( ONCS...
2023-04-03 09:36:17 ET Heron Therapeutics ( NASDAQ: HRTX ) appointed Craig Collard as CEO, effective immediately, succeeding Barry Quart, Pharm.D., who has stepped down as CEO and Chairman of the Board. The board elected Adam Morgan ...
Heron Therapeutics Announces New CEO and Board Chairman PR Newswire Craig Collard Appointed CEO Adam Morgan Named Chairman of the Board SAN DIEGO , April 3, 2023 /PRNewswire/ -- Heron Therapeutics, Inc. (NASDAQ: HRTX ) ("Heron" or the "Company...
2023-03-28 05:30:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
2023-03-24 11:31:28 ET Heron Therapeutics ( NASDAQ: HRTX ) stock fell ~12% on Friday despite Q4 results beat estimates as potential headwinds related to the label and the device delivery of Zynrelef lingered. Net loss narrowed to -$19.87M, compared to -$54.65Min Q4 ...
2023-03-24 10:01:43 ET Gainers: Dermata Therapeutics ( DRMA ) +40% . GH Research ( GHRS ) +27% . Vaccitech ( VACC ) +25% . Cosmos Health ( COSM ) +10% . Assure ( IONM ) +6% . Losers: BridgeBio Pharma ( BBIO ) -9%...
2023-03-24 08:36:57 ET The futures were pointing to a decline at the start of Friday's trading. Stocks gained the day before in choppy trading, as strength in technology overcame weakness in other parts of the market. Here are some stocks to watch on Friday: Deutsche Bank ( NYSE: ...
News, Short Squeeze, Breakout and More Instantly...
Heron Therapeutics Inc. Company Name:
HRTX Stock Symbol:
NASDAQ Market:
Heron Therapeutics Inc. Website:
Heron Therapeutics Announces the Inclusion of ZYNRELEF® as a Qualifying Product Under the Proposed 2025 Non-Opioid Policy for Pain Relief Under the OPPS and the ASC Payment System PR Newswire SAN DIEGO , July 15, 2024 /PRNewswire/ -- Heron Therapeutics, Inc....
Heron Therapeutics Announces Acceptance of the Prior Approval Supplement Application for ZYNRELEF® Vial Access Needle ("VAN") PR Newswire -The U.S. Food and Drug Administration ("FDA") assigned a Prescription Drug User Fee Act ("PDUFA") goal date of September 23, 2024 ...
Heron Therapeutics Announces Prior Approval Supplement Submission to the FDA for ZYNRELEF® Vial Access Needle ("VAN") PR Newswire SAN DIEGO , May 29, 2024 /PRNewswire/ -- Heron Therapeutics, Inc. (Nasdaq: HRTX) ("Heron" or the "Company"), a commercial-stage biotechn...